Editorial Comment on: Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes by Metcalfe et al
J Endourol
.
2017 Sep;31(9):954-955.
doi: 10.1089/end.2017.0536.
Author
Bhaskar K Somani
1
Affiliation
1
Department of Urology, University Hospitals Southampton NHS Trust , Southampton, United Kingdom .
PMID:
28762779
DOI:
10.1089/end.2017.0536
No abstract available
Publication types
Comment
MeSH terms
Adjuvants, Immunologic
Carcinoma, Transitional Cell*
Chemotherapy, Adjuvant
Humans
Kidney Neoplasms
Mitomycin*
Ureteral Neoplasms
Urologic Neoplasms
Substances
Adjuvants, Immunologic
Mitomycin